Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Editing02:23

RNA Editing

10.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
10.0K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High Throughput Evidence Generation to Support Tentative Gene Disease Relationship from A Cohort Enriched for Autozygosity and Founder Effect.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Expanding the ABCA2-associated neurodevelopmental phenotype.

HGG advances·2026
Same author

Pathomechanism of Fever-Induced Liver Failure in NBAS Deficiency and Treatment Effect of NAC-Observations In Vitro and In Vivo.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Accelerating Leigh syndrome drug discovery through deep learning screening in brain organoids.

Nature communications·2026
Same author

Diagnostic Criteria and Management of MELAS and Stroke-Like Episodes: Consensus-Based Statements.

European journal of neurology·2026
Same author

Bi-allelic WDHD1 variants cause microcephalic primordial dwarfism.

American journal of human genetics·2026

Related Experiment Video

Updated: Mar 9, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.2K

CAD mutations and uridine-responsive epileptic encephalopathy.

Johannes Koch1, Johannes A Mayr2, Bader Alhaddad3

  • 1Department of Pediatrics, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.

Brain : a Journal of Neurology
|December 24, 2016
PubMed
Summary

Genetic mutations in the CAD gene cause a severe developmental disorder with epilepsy and anemia. Oral uridine supplementation effectively treats this condition, offering a new therapeutic approach for affected children.

Keywords:
anaemiaanisopoikilocytosisepilepsyglobal developmental delayuridine

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.7K
Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research
04:41

Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research

Published on: October 13, 2023

2.3K

Related Experiment Videos

Last Updated: Mar 9, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.2K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.7K
Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research
04:41

Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research

Published on: October 13, 2023

2.3K

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Unexplained global developmental delay and epilepsy in childhood represent a significant socioeconomic challenge.
  • Effective treatments for rare neurometabolic disorders are often lacking, despite advances in molecular diagnostics.
  • Inborn errors of metabolism treatable by dietary intervention are notable exceptions.

Purpose of the Study:

  • To identify the genetic cause of a severe neurometabolic disorder characterized by global developmental delay, epileptic encephalopathy, and anemia.
  • To investigate the therapeutic potential of uridine supplementation in patients with identified genetic defects.

Main Methods:

  • Exome sequencing was performed on three families with affected children.
  • Genetic variants were identified and correlated with clinical phenotypes.
  • The efficacy of oral uridine supplementation was assessed in surviving patients.

Main Results:

  • Biallelic mutations in the CAD gene were identified in four children presenting with global developmental delay, epileptic encephalopathy, and dyserythropoietic anemia.
  • Two affected children experienced a fatal neurodegenerative course.
  • Uridine supplementation led to immediate seizure cessation and significant developmental improvements in the surviving children, with normalization of blood smears and resolution of anemia.

Conclusions:

  • CAD deficiency is a treatable neurometabolic disorder characterized by global developmental delay, anemia, and seizures.
  • Uridine supplementation represents a highly effective treatment, significantly improving neurological and hematological parameters.
  • CAD deficiency is a potential candidate for inclusion in future newborn screening programs due to its treatable nature.